Navigation Links
New Data Shows FusionHealth Sleep Apnea Therapy Reaches Industry-High Results
Date:7/24/2017

A new report released today by FusionHealth, the first comprehensive sleep management solution focused on delivering end-to-end sleep health care at scale, indicates record-breaking adherence results for the company’s obstructive sleep apnea (OSA) program.

Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, the most widely utilized treatment for OSA, typically range between 40 to 60 percent. Today, FusionHealth reported that, across approximately 4,000 users over a 5 year period, 91 percent of participants remained actively engaged in PAP therapy, with an average use of 6.7 days per week at a rate of 6.5 hours per night. These statistics far exceed all regulatory requirements and current clinical practice standards.

In addition, FusionHealth reports that the average participant’s Apnea–Hypopnea Index (AHI), which measures the frequency of sleep-disrupting respiratory events per hour, dropped from a pre-treatment average of 43 per hour (considered severe) to an on-treatment average of 1.5 per hour (considered normal). Furthermore, given that 90 percent of FusionHealth participants remain in therapy for multiple years, not only is healthy sleep restored, but risk for sleep-related chronic comorbidities like obesity, hypertension and cardiovascular disease is reduced.

Lastly, as determined by a well-known clinically-validated quality of life assessment, after the first 90 days of treatment FusionHealth participants experienced a 19 percent improvement in mental health, a 14 percent improvement in physical health, a 25 percent increase in vitality and a 38 percent improvement in their general health and well-being. While participants have experienced individual results, their employers are also seeing direct financial benefits such as a 20 percent savings year-over-year in healthcare costs.

“Treatment for disorders such as obstructive sleep apnea are only effective when they are used,” said Dr. Jeffrey Durmer, co-founder and chief medical officer of FusionHealth. “Unfortunately, a lack of adherence to traditional treatments like PAP therapy is a common problem. As a result, patients not only continue to suffer from poor sleep, but a host of other health issues related to their untreated OSA. That is why the advances made by FusionHealth in this space are so important – not only are more patients given access to treatment, but they are twice as likely to continue their vital therapy under our model.”

ABOUT FUSIONHEALTH
FusionHealth, headquartered in Atlanta, is a sleep health technology company that provides employers and healthcare systems with population-based solutions to address the central problem of poor sleep health. Partnering with FusionHealth, businesses reduce their healthcare spend, improve safety, increase productivity and improve the overall well-being of their workforce. For more information, visit http://www.fusionhealth.com.

Read the full story at http://www.prweb.com/releases/fusionhealth/dr-jeffrey-durmer/prweb14533384.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. New Poll Shows CalUniversity and Other Accredited Online Colleges Best Value for Education
2. Prosthetic hands viewed as eerie by the public new study shows
3. 4leafcity.com Shows Its New Men’s Tweed Coat Designs
4. BUSM/BMC study shows decrease in sepsis mortality rates
5. Impulsivity, rewards and Ritalin: Monkey study shows tighter link
6. "Get Rid of Cold Sores Fast" Review Shows How to Overcome Cold Sores in 12 Hours
7. Nanotech researchers 2-step method shows promise in fighting pancreatic cancer
8. Drug shows early promise in treating seizures
9. Depression in pregnancy: New study shows preferences for therapy over medication
10. New study shows spironolactone reduces heart failure hospitalizations, but not mortality
11. Advanced CT imaging proves as accurate as invasive tests to assess heart blockages, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
Breaking Medicine Technology: